Bessemer Group
AMRX icon

Bessemer Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Bessemer Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
659
+410
+165% +$5.62K ﹤0.01% 2131
2026
Q1 		$3K Hold
249
– – ﹤0.01% 2299
2025
Q4 		$3K Hold
249
– – ﹤0.01% 2315
2025
Q3 		$2K Hold
249
– – ﹤0.01% 2286
2025
Q2 		$2K Buy
+249
New +$1.88K ﹤0.01% 2172
2024
Q4 		– Sell
-160
Closed -$1K – 2445
2024
Q3 		$1K Buy
+160
New +$1.25K ﹤0.01% 2318
2019
Q2 		– Sell
-2,500
Closed -$35K – 1633
2019
Q1 		$35K Hold
2,500
– – ﹤0.01% 1332
2018
Q4 		$34K Buy
+2,500
New +$45.1K ﹤0.01% 1403

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Bessemer Group's AMRX Position: Q2 2026 in Review

Bessemer Group increased its Amneal Pharmaceuticals (AMRX) stake by 165% in Q2 2026, buying an estimated $5.62K and bringing the position to 659 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2131.

Bessemer Group first reported a position in AMRX in Q4 2018 and has held it in 8 quarters since. The position peaked at $35K in Q1 2019. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Bessemer Group held 659 shares of Amneal Pharmaceuticals worth $11K as of Q2 2026.
  • Bessemer Group bought 410 Amneal Pharmaceuticals shares in Q2 2026, an estimated $5.62K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2131 holding.
  • Bessemer Group first reported a position in Amneal Pharmaceuticals in Q4 2018 and has held it in 8 quarters since.
  • Bessemer Group's Amneal Pharmaceuticals position peaked at $35K in Q1 2019.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.